Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

ClinicalTrials.gov ID: NCT04964089

Public ClinicalTrials.gov record NCT04964089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 study will evaluate the efficacy and safety of KSI-301 compared to aflibercept, in participants with neovascular (wet) age-related macular degeneration (wAMD)

Study identification

NCT ID
NCT04964089
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kodiak Sciences Inc
Industry
Enrollment
557 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 23, 2021 (Actual)
Primary completion
Mar 28, 2023 (Actual)
Completion
Apr 6, 2023 (Actual)
Last update posted
Jul 3, 2024

2021 – 2023

United States locations

U.S. sites
65
U.S. states
28
U.S. cities
63
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014 —
Northwest Arkansas Retina Associates Springdale Arkansas 72762 —
California Retina Consultants Bakersfield California 93309 —
Eye Medical Center of Fresno Fresno California 93720 —
Retina Consultants of Orange County Fullerton California 92835 —
UCSD Jacobs Retina Center La Jolla California 92037 —
Retina Associates of Orange County Laguna Hills California 92653 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Retina Consultants of San Diego Poway California 92064 —
Retina Consultants of Southern California Redlands California 92374 —
Retinal Consultants Medical Group Inc Sacramento California 95819 —
Orange County Retina Medical Group Santa Ana California 92705 —
Colorado Retina Associates PC Lakewood Colorado 80228 —
Retina Group of New England Waterford Connecticut 06385 —
Florida Eye Microsurgical Institute Boynton Beach Florida 33426 —
Rand Eye Institute Deerfield Beach Florida 33064 —
Retina Health Center Fort Myers Florida 33907 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Florida Eye Associates Melbourne Florida 32901 —
Retina Specialty Institute Pensacola Florida 32503 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33703 —
Retina Associates of Florida Tampa Florida 33609 —
Southeast Retina Center Augusta Georgia 30909 —
University of Chicago Chicago Illinois 60637 —
Springfield Clinic LLP Springfield Illinois 62703 —
Talley Eye Evansville Indiana 47710 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates PA Lenexa Kansas 66215 —
Retina Associates of Kentucky Lexington Kentucky 40509 —
Retina Group of Washington Chevy Chase Maryland 20815 —
Cumberland Valley Retina Consultants PC Hagerstown Maryland 21740 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
New England Retina Consultants Springfield Massachusetts 01103 —
Vitreo Retinal Associates PC Worcester Massachusetts 01603 —
Foundation for Vision Research Grand Rapids Michigan 49525 —
Associated Retinal Consultants PC Royal Oak Michigan 78073 —
Vitreoretinal Surgery PA Edina Minnesota 55435 —
Sierra Eye Associates Reno Nevada 89502 —
The Retina Center of New Jersey Bloomfield New Jersey 07017 —
NJ Retina Teaneck New Jersey 07605 —
Retina-Vitreous Surgeons of Central NY Liverpool New York 13088 —
Retina Associates of Western NY Rochester New York 14620 —
Western Carolina Retinal Associate PA Asheville North Carolina 28803 —
Retina Associates of Cleveland Cleveland Ohio 44130 —
Cleveland Clinic Foundation, Cole Eye Institute Cleveland Ohio 44195 —
Retina Northwest Portland Oregon 97210 —
Retina Consultants, LLC Salem Oregon 97302 —
Cascade Medical Research Institute Springfield Oregon 97477 —
MidAtlantic Retina Philadelphia Pennsylvania 19107 —
Retina Research of Beaufort Beaufort South Carolina 29902 —
Charleston Neuroscience Institute Ladson South Carolina 29456 —
Palmetto Retina Center West Columbia South Carolina 296169 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates PC Knoxville Tennessee 37909 —
Tennessee Retina PC Nashville Tennessee 37203 —
Retina Research Institute of Texas Abilene Texas 79606 —
Austin Retina Associates Austin Texas 78705 —
Retina Consultants of Texas Houston Texas 77030 —
Retina Consultants of Texas-(Katy) Katy Texas 77494 —
Texas Retina Associates Plano Texas 75075 —
Austin Retina Associates (Round Rock) Round Rock Texas 78681 —
Medical Center Ophthalmology Associates San Antonio Texas 78240 —
Retina Consultants of Texas - (Woodlands) The Woodlands Texas 77384 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
Spokane Eye Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04964089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04964089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →